Provided by Tiger Trade Technology Pte. Ltd.

Anavex Life Sciences

3.24
+0.11003.51%
Post-market: 3.21-0.0300-0.93%19:30 EDT
Volume:480.79K
Turnover:1.56M
Market Cap:300.26M
PE:-8.39
High:3.29
Open:3.17
Low:3.16
Close:3.13
52wk High:10.40
52wk Low:2.26
Shares:92.67M
Float Shares:91.12M
Volume Ratio:0.87
T/O Rate:0.53%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.3863
EPS(LYR):-0.5438
ROE:-30.78%
ROA:-19.50%
PB:2.47
PE(LYR):-5.96

Loading ...

Top News Today: Stocks Fall, Oil Rises as US-Iran Tensions Mount

Dow Jones
·
Aug 18

Press Release: Anavex Life Sciences Mails Letter to Stockholders Reinforcing Relevant Experience of All Six Director Nominees

Dow Jones
·
Aug 17

Anavex Life Sciences Files Proxy, Urges Director Support

TIPRANKS
·
Aug 12

Anavex Life Sciences Highlights Highly Qualified Board and Decisive Actions to Create Long-Term Value for Stockholders

THOMSON REUTERS
·
Aug 11

Anavex Faces PVG Activist Slate Seeking Board Seats at Sept. 24 Shareholder Meeting

Reuters
·
Aug 11

Anavex Life Sciences Delays Quarterly SEC Filing

TIPRANKS
·
Aug 11

Anavex Life Sciences Delays Filing Quarterly Report for June 30, 2026 Quarter

Reuters
·
Aug 11

Top News Today/Canada: Barrick Settles Newmont Dispute, Clearing Way to List Its Gold Assets

Dow Jones
·
Aug 11

Anavex Life Sciences Corp Expected to Post a Loss of 8 Cents a Share - Earnings Preview

Reuters
·
Aug 07

Anavex Life Sciences Aims to Refresh Board with Two New Candidates

Dow Jones
·
Aug 03

Anavex Urges Investors to Reject PVG Proxy Bid to Replace Entire Board at 2026 Annual Meeting

Reuters
·
Aug 03

Anavex Life Sciences Announces Plans to Refresh Board to Continue Overseeing Critical Progress and Stockholder Value Creation

THOMSON REUTERS
·
Aug 03

Anavex Life Sciences Corp - Nominates Gautam Patel and Adrian Senderowicz as Independent Directors

THOMSON REUTERS
·
Aug 03

Anavex Life Sciences Corp - Urges Stockholders to Reject Pvg Asset Management and Patrick S. Adams Control Attempt

THOMSON REUTERS
·
Aug 03

Anavex Life Sciences Corp - Files Preliminary Proxy Statement with SEC on July 31, 2026

THOMSON REUTERS
·
Aug 03

Anavex Life Sciences Corp - Christopher Missling and Steffen Thomas to Leave Board After 2026 Annual Meeting

THOMSON REUTERS
·
Aug 03

Promising Penny Stocks To Consider In August 2026

Simply Wall St.
·
Aug 03

Anavex Urges Vote for Its Six Director Nominees as PVG Group Seeks Board Seats Ahead of Annual Meeting

Reuters
·
Aug 01

Werewolf Therapeutics Posts Q2 Profit on Jazz Asset Sale

Reuters
·
Jul 31

Tenax Therapeutics Q2 Net Loss Widens on Higher R&D Costs

Reuters
·
Jul 31